Ainhoa Echeverria Larraza

Title: Ainhoa Echeverria Larraza: Innovator in Neuroprotection

Introduction

Ainhoa Echeverria Larraza is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of neuroprotection through her innovative research and patent applications. Her work focuses on the development of antibodies that target specific receptors involved in neurodegenerative processes.

Latest Patents

Ainhoa holds 1 patent related to her groundbreaking work. The patent, titled "Agonists of TREM2," discloses antibodies that specifically bind to human TREM2, a receptor expressed on myeloid cells. These antibodies act as TREM2 agonists and have the potential to enhance neuroprotective activities. The patent details how these antibodies can inhibit the shedding of soluble TREM2 and improve the survival of human microglia cells, thereby contributing to neuroprotection.

Career Highlights

Ainhoa is currently employed at Genentech, Inc., where she continues her research in the field of neurobiology. Her innovative approach to understanding TREM2's role in neurodegenerative diseases has positioned her as a key figure in her field.

Collaborations

Throughout her career, Ainhoa has collaborated with notable colleagues, including David Verne Hansen and Isidro Hotzel. These collaborations have further enriched her research and contributed to the advancement of neuroprotective therapies.

Conclusion

Ainhoa Echeverria Larraza is a trailblazer in the field of neuroprotection, with her innovative patents and research making a significant impact. Her work at Genentech, Inc. and collaborations with esteemed colleagues highlight her dedication to advancing scientific knowledge and therapeutic options.